Lv41
460 积分 2024-05-15 加入
ASP3082, a First-in-class novel KRAS G12D degrader, exhibits remarkable anti-tumor activity in KRAS G12D mutated cancer models
2个月前
已完结
Identification and characterization of TYK2 pseudokinase domain stabilizers that allosterically inhibit TYK2 signaling
2个月前
已完结
Overview of High‐Throughput Screening
2个月前
已完结
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
2个月前
已完结
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo
3个月前
已完结
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion
3个月前
已关闭
Computer Aided Drug Design: Success and Limitations
3个月前
已完结
皖公网安备34019202002308
